These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [GM-CSF: its use in onco-hematologic diseases]. Visani G; Tosi P; Benfenati D; Colombini R; Cenacchi AR; Gamberi B; Lemoli RM; Tura S Haematologica; 1989 Oct; 74(5 Suppl):501-10. PubMed ID: 2512232 [No Abstract] [Full Text] [Related]
5. Stimulation of myelopoiesis in a patient with congenital neutropenia: biology and nature of response to recombinant human granulocyte-macrophage colony-stimulating factor. Vadhan-Raj S; Jeha SS; Buescher S; LeMaistre A; Yee G; Lu L; Lloreta J; Hoots WK; Hittelman WN; Gutterman JU Blood; 1990 Feb; 75(4):858-64. PubMed ID: 2405922 [TBL] [Abstract][Full Text] [Related]
6. Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy. Herrmann F; Schulz G; Wieser M; Kolbe K; Nicolay U; Noack M; Lindemann A; Mertelsmann R Am J Med; 1990 Jun; 88(6):619-24. PubMed ID: 2189305 [TBL] [Abstract][Full Text] [Related]
7. Growth factor-assisted chemotherapy--the Manchester experience. Crowther D; Scarffe JH; Howell A; Thatcher N; Bronchud M; Steward WP; Testa N; Dexter M Ciba Found Symp; 1990; 148():201-10; discussion 211-4. PubMed ID: 1690624 [TBL] [Abstract][Full Text] [Related]
8. Treatment of neutropenia associated with dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor. Russo CL; Glader BE; Israel RJ; Galasso F Lancet; 1990 Sep; 336(8717):751-2. PubMed ID: 1975922 [No Abstract] [Full Text] [Related]
9. The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropenia. Ganser A; Ottmann OG; Erdmann H; Schulz G; Hoelzer D Ann Intern Med; 1989 Dec; 111(11):887-92. PubMed ID: 2683920 [TBL] [Abstract][Full Text] [Related]
10. [Clinical effects of P-100 (CSF-HU) in chronic neutropenia of childhood]. Komiyama A; Ishiguro A; Akabane T; Tsuchida M; Tsukimoto I; Hanawa Y; Higuchi S; Matsuda I; Nakazawa S; Yamamoto M Rinsho Ketsueki; 1988 Sep; 29(9):1365-70. PubMed ID: 3063853 [No Abstract] [Full Text] [Related]
11. Congenital neutropenia: a case study. Daghistani D; Jimenez JJ; Toledano SR; Cirocco RE; Yunis AA Am J Pediatr Hematol Oncol; 1990; 12(2):210-4. PubMed ID: 1696074 [TBL] [Abstract][Full Text] [Related]
12. Agranulocytosis associated with T-gamma-lymphocytosis: no improvement of peripheral blood granulocyte count with human-recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF). Thomssen C; Nissen C; Gratwohl A; Tichelli A; Stern A Br J Haematol; 1989 Jan; 71(1):157-8. PubMed ID: 2644967 [No Abstract] [Full Text] [Related]
13. Clinical use of GM-CSF in autologous bone marrow transplantation. Carella AM; Gaozza E; Piatti G; Giordano D; Santini G; Carlier P; Raffo MR; Nati AS; Congin A; Bacigalupo A Int J Cell Cloning; 1990 Jan; 8 Suppl 1():279-82. PubMed ID: 2182740 [TBL] [Abstract][Full Text] [Related]
14. Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy. Herrmann F; Schulz G; Wieser M; Kolbe K; Nicolay U; Noack M; Lindemann A; Mertelsmann R Haematol Blood Transfus; 1990; 33():717-23. PubMed ID: 2182461 [TBL] [Abstract][Full Text] [Related]
15. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Morstyn G; Campbell L; Souza LM; Alton NK; Keech J; Green M; Sheridan W; Metcalf D; Fox R Lancet; 1988 Mar; 1(8587):667-72. PubMed ID: 2895212 [TBL] [Abstract][Full Text] [Related]
16. The promise of colony-stimulating factors in clinical practice. Glaspy JA; Ambersley JM Oncol Nurs Forum; 1990; 17(1 Suppl):20-4. PubMed ID: 1689043 [TBL] [Abstract][Full Text] [Related]
17. Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor. Morstyn G; Lieschke GJ; Sheridan W; Layton J; Cebon J; Fox RM Semin Hematol; 1989 Apr; 26(2 Suppl 2):9-13. PubMed ID: 2471275 [TBL] [Abstract][Full Text] [Related]
18. Protective effect of human granulocyte colony-stimulating factor on bacterial and fungal infections in neutropenic mice. Ono M; Matsumoto M; Matsubara S; Tomioka S; Asano S Behring Inst Mitt; 1988 Aug; (83):216-21. PubMed ID: 2467649 [TBL] [Abstract][Full Text] [Related]
19. Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy. Morstyn G; Campbell L; Lieschke G; Layton JE; Maher D; O'Connor M; Green M; Sheridan W; Vincent M; Alton K J Clin Oncol; 1989 Oct; 7(10):1554-62. PubMed ID: 2789274 [TBL] [Abstract][Full Text] [Related]
20. Biology and clinical applications of human recombinant granulocyte colony-stimulating factor. Gabrilove JL Cancer Invest; 1990; 8(2):295-7. PubMed ID: 1698112 [No Abstract] [Full Text] [Related] [Next] [New Search]